29,489 Followers on Owler
OverviewCompetitorsAcquisitionsFundingInvestmentsNews & Insights

AbbVie Acquisitions

AbbVie has acquired 14 companies and its latest acquisition was Nimble Therapeutics, Inc on Dec 2024

Unlock 11 more acquisitions →
COMPANY ACQUIRED
ACQUISITION DATE
AMOUNT
DESCRIPTION
Nimble Therapeutics, Inc

Dec 2024

Source »
$200M
Nimble Therapeutics is a biotechnology company that commercializes proprietary chemical synthesis technology for drug discovery and development.
Aliada Therapeutics, Inc.

Oct 2024

Source »
$1.4B
-
Celsius Therapeutics, Inc.

Jun 2024

Source »
$250M
Celsius is a Massachusetts-based biotechnology company that researches and develops RNA-based therapeutics for the treatment of inflammatory diseases.
Landos Biopharma, Inc.

Mar 2024

Source »
$137.5M
Landos Biopharma is a Virginia-based biopharmaceutical company that discovers and develops oral therapeutics for the treatment of autoimmune diseases.
Cerevel Therapeutics, Inc.

Dec 2023

Source »
$8.7B
Cerevel is a Massachusetts-based biopharmaceutical company that develops and commercializes novel therapeutics for the treatment of neuroscience diseases.

Frequently Asked Questions about AbbVie

  1. What companies did AbbVie acquire?

    Companies acquired by AbbVie include Nimble Therapeutics, Aliada Therapeutics and Celsius Therapeutics

  2. How many acquisitions does AbbVie have?

    AbbVie has acquired 14 companies including Nimble Therapeutics, Aliada Therapeutics and Celsius Therapeutics.

  1. How many acquisitions did AbbVie make in 2024?

    In 2024 AbbVie acquired 4 companies including Nimble Therapeutics, Aliada Therapeutics and Celsius Therapeutics.